Chronic News and Research

RSS

Afferent Pharmaceuticals' P2X3 receptor antagonist reduces bladder hyperactivity

Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.

26 Aug 2010

FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy

Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.

26 Aug 2010

Angeion Corporation 2010 third quarter revenue increases to $7.1 million

Angeion Corporation today reported results for its fiscal third quarter ended July 31, 2010.

26 Aug 2010

Plantain and broccoli fiber help in Crohn’s disease: Study

New research suggests that plant fibers in plantains and broccoli can help prevent relapses of Crohn's disease. This disease is a long term disease of the gut that is characterized by inflammation of the lining of the digestive system, with symptoms including diarrhea and abdominal pain. Crohn's disease affects between 400,000 and 600,000 people in North America. Scientists believe that rise in processed food and decrease in fibers in diet could be a reason for rise of incidence of this disease.

25 Aug 2010

Fox Chase Cancer Center to host Philadelphia Chromosome Symposium

In celebration of a seminal discovery in cancer biology, Fox Chase Cancer Center will host the Philadelphia Chromosome Symposium: Past, Present and Future, on September 28, 2010, from 8 a.m. to 7 p.m. at The Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia. The event marks the 50th anniversary of the discovery of the first genetic abnormality associated with cancer, and the first to lead to a targeted therapy for cancer.

25 Aug 2010

Synovis Life Technologies third-quarter net revenue increases 17% to $17.6 million

Synovis Life Technologies, Inc., today reported its financial results for the third quarter ended July 31, 2010.

25 Aug 2010

Preliminary results from Phase 3 AVERROES trial in atrial fibrillation to be presented at cardiology congress 2010

Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.

25 Aug 2010

ZymoGenetics completes enrollment in Phase 2b PEG-IFN lambda clinical trial

ZymoGenetics, Inc. today announced enrollment has been completed in the Phase 2b clinical trial with PEG-Interferon lambda and ribavirin in chronic hepatitis C virus (HCV) infection.

25 Aug 2010

Study identifies four genetic variants associated with ESRD disease in Chinese diabetic patients

Examination of a gene involved in cell signaling finds that four common variants of this gene are associated with the development of end-stage renal disease in Chinese patients with type 2 diabetes, according to a study in the August 25 issue of JAMA.

25 Aug 2010

CAS researchers confirm Gleevec’s first generation drug targets chronic myelogenous leukemia

Today, leukemia patients who have struggled with cancer therapy resistance and intolerance will now have more options thanks to targeted drug therapy. Such new treatment options are due, in part, to a rapid increase in journal and patent publications following the discovery of Gleevec, as reported by Chemical Abstracts Service (CAS), the world's authority for chemical information.

25 Aug 2010

Jordan Hospital receives approval to open new Wound Healing and Hyperbaric Center

Jordan Hospital is pleased to announce that it has received approval from the Massachusetts Department of Public Health for the opening of its new, state-of-the-art Wound Healing and Hyperbaric Center located on the hospital campus in Plymouth, Mass. The Wound Center features the only hospital-based hyperbaric treatment chamber in the greater Plymouth and Cape Cod region. The new Wound Center provides individuals with chronic, non-healing wounds, a local option for wound care and hyperbaric therapy.

25 Aug 2010

American Medical Group Association to participate in COPD care management

The American Medical Group Association (AMGA) and the American Medical Group Foundation (AMGF) are pleased to announce an opportunity for AMGA members to participate in a learning collaborative on care management for patients with COPD. The Best Practices Learning Collaborative is for organizations that are striving to improve the care of patients with COPD.

25 Aug 2010

Sleep deprivation and chronic disease

Sleep experts believe that sleep deprivation and inadequate sleep is becoming frightfully common and it can be bad for health in more ways than one. According to Harvard School of Medicine's Healthy Sleep site there is a real link between chronic diseases like diabetes, heart disease and depression and chronic lack of sleep.

24 Aug 2010

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

UK scientists at the University of Oxford have discovered that vitamin D can affect the activity of more than 200 genes of cells grown in the lab. Some of these genes are known from previous studies to be involved in diseases like diabetes and cancer.

24 Aug 2010

Assured Pharmacy reports 20.8% increase in same store sales

OTC Stock Review announces that it has initiated coverage of Assured Pharmacy, Inc. Assured Pharmacy, a growing chain of specialty pharmacies specializing in servicing patients who live with chronic pain, just reported a 20.8 percent increase in same store sales for June 2010 versus June 2009.

24 Aug 2010

PHLBI announces launch of new website for patients

The Pacific Heart, Lung & Blood Institute, a non-profit medical research institute focusing on the treatment and prevention of malignant pleural mesothelioma, is proud to announce the launch of its new website: http://www.phlbi.org.

24 Aug 2010

Highmark Foundation’s report documents status of safety net providers to improve health outcomes

Efforts made from a four-year, $4.1 million investment to help safety net providers meet the health care needs of the uninsured are documented in a recent Highmark Foundation report.

24 Aug 2010

Pharmasset commences dosing in PSI-7977 Phase 2b study for chronic hepatitis C

Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients with HCV genotype 1 who have not been treated previously.

24 Aug 2010

Canadian Nurses Association to lead in development of national strategy for aging and health

The Canadian Nurses Association (CNA) is poised to take on a leadership role in developing a national strategy for aging and health as Canadians reveal they are increasingly worried about the future of their health-care system.

24 Aug 2010

BTE, Leapfrog Group, and PROMETHEUS Payment support NBCH's eValue8 health plan evaluation program

As the U.S. moves forward with health reform, health care purchasers are working to eliminate waste, overuse, and misuse in the health care system at the point of care. To that end, several of the nation's foremost quality and measurement organizations – Bridges to Excellence (BTE), the Leapfrog Group, and PROMETHEUS Payment® – announced their support of eValue8™, a program of the National Business Coalition on Health (NBCH).

24 Aug 2010

Chronic News and Research

Afferent Pharmaceuticals' P2X3 receptor antagonist reduces bladder hyperactivity

FDA approves brand name VELETRI for Actelion's epoprostenol for injection therapy

Angeion Corporation 2010 third quarter revenue increases to $7.1 million

Plantain and broccoli fiber help in Crohn’s disease: Study

Fox Chase Cancer Center to host Philadelphia Chromosome Symposium

Synovis Life Technologies third-quarter net revenue increases 17% to $17.6 million

Preliminary results from Phase 3 AVERROES trial in atrial fibrillation to be presented at cardiology congress 2010

ZymoGenetics completes enrollment in Phase 2b PEG-IFN lambda clinical trial

Study identifies four genetic variants associated with ESRD disease in Chinese diabetic patients

CAS researchers confirm Gleevec’s first generation drug targets chronic myelogenous leukemia

Jordan Hospital receives approval to open new Wound Healing and Hyperbaric Center

American Medical Group Association to participate in COPD care management

Sleep deprivation and chronic disease

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

Assured Pharmacy reports 20.8% increase in same store sales

PHLBI announces launch of new website for patients

Highmark Foundation’s report documents status of safety net providers to improve health outcomes

Pharmasset commences dosing in PSI-7977 Phase 2b study for chronic hepatitis C

Canadian Nurses Association to lead in development of national strategy for aging and health

BTE, Leapfrog Group, and PROMETHEUS Payment support NBCH's eValue8 health plan evaluation program

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News